STK32C and colorectal cancer: In summary, in our current study, STK32C was overexpressed in HCT116, HT29, SW480, and SW620 colorectal cancer cells compared to CCD-18Co normal fibroblast cells, and its overexpression was associated with poor OS and DFS rates.